Discover the possibility of continuous respiratory insights for enhanced COPD research.
We aim to collaborate with researchers in the field to enhance the research process, streamlining extensive data collection and simplifying participation requirements.
Our cutting-edge hardware and data collection platform redefines research possibilities. Reduce costs and time associated with COPD research. Unearth new patterns and evidence for exacerbation triggers, advancing understanding of disease progression.
Gain access and actively contribute to the refinement of the most advanced Early Warning System (EWS).
This empowers healthcare providers with the tools they need to identify subtle changes in vital parameters, enabling timely intervention and preventing exacerbations.
Designed for ease-of-use, our non-demanding wearable device ensures a seamless experience for participants throughout the monitoring process.
Simplify participation demands and requirements, enhancing patient engagement in research and monitoring.
Respiratory Medicine Case Reports, Volume 34 (July, 2021)
“COPD exacerbations are underreported by patients which leads to worse outcomes.
Conversely, when early therapies for exacerbations are instituted, patients have shorter symptom duration, improved quality of life as well as decreased hospitalizations.
The use of respiratory RPM has the potential to reduce COPD treatment delays leading to improved care.”
American Journal of Respiratory and Critical Care Medicine, Volume 169, Issue 12 (June, 2004)
“Treatment of chronic obstructive pulmonary disease (COPD) exacerbations improves outcomes. Earlier treatment was associated with a faster recovery. Patients who reported a higher proportion of exacerbations for treatment had better health-related quality of life than those patients with more untreated exacerbations. Failure to report exacerbations was associated with an increased risk of emergency hospitalization.”
Chronic Respiratory Disease, Volume 13, Issue 3 (June, 2016)
“Reducing the impact of exacerbations through the early recognition of symptoms and prompt treatment may reduce the risk of hospitalization, improve health-related quality of life (HRQoL) and control the burden of COPD.”
Our Early Warning System employs a cutting-edge AI algorithm to identify exacerbations in their early stages. The significance? Early detection and subsequent treatment of these exacerbations, which have been scientifically shown to enhance patient outcomes.
We are actively seeking collaborations with researchers to conduct testing and validation of our product.
Your insights are invaluable as we strive to create a state-of-the-art solution that serves patients, healthcare providers, and researchers alike.
As we prepare for clinical trials, your input is crucial to our success!
If you’re interested in collaborating with us or have any questions, please don’t hesitate to get in touch!
We want to hear from you! Send us an email with your informations and interest in use.
[email protected]